# Ocelot Bio, Inc. — Form D

Ocelot Bio, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-15. The offering totals $38.0M, of which $36.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-04-15
- Form: D
- Accession: 0001567619-21-008088
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $38.0M
- Amount sold: $36.0M
- Remaining: $2.0M
- Investors: 5
- Date of first sale: 2021-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-395929

## Issuer

- Name: Ocelot Bio, Inc.
- CIK: 0001856030
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 12670 High Bluff Drive, San Diego, CA, 92130
- Phone: (858) 247-2272

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Geoffrey Harris | Director | Iowa City, IA |
| Geoffrey Harris | Executive Officer | Iowa City, IA |
| Camille Samuels | Director | South San Francisco, CA |
| Jack Nielsen | Director | Palo Alto, CA |
| Donald Santel | Director | San Diego, CA |
| Katherine Stultz | Director | San Diego, CA |
| Katherine Stultz | Executive Officer | San Diego, CA |
| Jennifer Schranz | Director | San Diego, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-07-13](https://search.stillhousedata.com/formd/0001567619-23-006568) | D | $12.0M | $3.0M |

## More

- [CIK 1856030 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1856030&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-21-008088.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
